research tirzepatide peptide Dual Agonist (GLP-1/GIP) Tirzepatide 5mg Research Pen Device

15, 2025 (GLOBE NEWSWIRE) -- The "Anti-Obesity Drugs Market Industr

As 2025 gets underway, we take a look at what lies ahead for the highly dynamic market for effective anti-obesity medications (AOMs)

Are you suffering from depression, chronic pain, or symptoms of opiate withdrawal

GLP-1 ilalar (Ozempic, Mounjaro vb.) ksa/orta vadede kilo kayb ve tip 2 diyabet kontrolnde etkili bulunurken, kalp-damar, bbrek ve gastrointestinal sistem zerindeki uzun sreli etkileri konusu halen netlememi durumda uzmanlar daha kapsaml uzun dnem verilerine ihtiya olduunu belirtiyor.

Learn about tirzepatide's low intrinsic risk when used alone, how combination therapy increases hypoglycemia risk, and essential safety guidance for patients and clinicians.